Back to search
FDAFDA · Food and drugs·Recall number Z-2682-2024

BIOFIRE FILMARRAY Pneumonia Panel, REF: RFIT-ASY-0144

Published August 28, 2024 · Recall initiated: June 10, 2024

Summary

FDA records medical device Class II recall Z-2682-2024, published August 28, 2024 and initiated June 10, 2024. Recalling firm: BioFire Diagnostics, LLC; Status: Ongoing; Reported quantity: 58; Lot: UDI-DI: 00815381020178. Lot/Expiration: 2147623/28-Aug-2024, 2147523/27-Aug-2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Pneumonia panels have an increased risk of control failures due to an issue in the manufacturing process, which could lead to delayed results for the customer.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
BioFire Diagnostics, LLC
Distributor
Worldwide - US Nationwide distribution in the states of WV, IN, AL and the countries of France, Italia, Spain, Greece, Japan Ltd, Singapore, Chile, Taiwan, Israel, Romania, Ecuador, Serbia.
Lot
UDI-DI: 00815381020178. Lot/Expiration: 2147623/28-Aug-2024, 2147523/27-Aug-2024
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was BIOFIRE FILMARRAY Pneumonia Panel, REF: RFIT-ASY-0144 recalled?

Yes. FDA published recall Z-2682-2024 on August 28, 2024. Reported hazard: Pneumonia panels have an increased risk of control failures due to an issue in the manufacturing process, which could lead to delayed results for the customer.

What should I do if I have this product?

Voluntary: Firm initiated · Letter